Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lopinavir (Kaletra) (2 trials)
maraviroc (selzentry) (1 trial)
ritonavir (Norvir) (2 trials)
vitamin d3 (1 trial)
abacavir (ziagen) (1 trial)
efavirenz (sustiva) (1 trial)
emtricitabine (emtriva) (1 trial)
raltegravir (isentress) (1 trial)
tenofovir (viread) (2 trials)
HIV Infections (Phase 4)
Trials (5 total)
Trial APIs (9 total)